Rima Jubran, MD

Title(s)Professor of Clinical Pediatrics (Educational Scholar)
SchoolKeck School of Medicine of Usc
AddressCHL 4650 Sunset Blvd
Off Campus
Los Angeles CA 90027
Phone+1 323 361 5639
vCardDownload vCard
    Other Positions
    Title(s)Designated Institute Official for CHLA

    Title(s)GEMS Working Group Co-Leader

    Collapse Biography 
    Collapse Education and Training
    Case Western Reserve University School of Medicine, Cleveland, OHMD05/1992Medicine
    George Washington University, Washington, DCMPH05/1999Public Health Policy
    University of Southern California, Los Angeles, CAMACM05/2012Academic Medicine
    Collapse Awards and Honors
    Drexel University2020  - 2021The Hedwig van Ameringen Executive Leadership in Academic Medicine
    University of Southern California2023USC Academic Senate Faculty Service Award
    Children's Hospital Los Angeles2011Walter Laug Distinguished Teaching Award
    Keck School of Medicine of USC2012Outstanding Teaching in Professionalism in the Practice of Medicine
    Keck School of Medicine of USC2015Outstanding Teaching in Professionalism in the Practice of Medicine

    Collapse Overview 
    Collapse Overview
    Rima Fuad Jubran, MD, MPH, MACM is the Designated Institutional Official and Director of Graduate Medical Education at Children's Hospital Los Angeles, where she oversees all physician training programs. In addition, Dr. Jubran is a pediatric oncologist who cares for patients with retinoblastoma, histiocytic disorders and solid tumors. She received her medical degree from Case Western Reserve University School of Medicine, Cleveland, Ohio, and her Master of Public Health at George Washington University, Washington, D.C. Following her residency at Rainbow Babies and Children's Hospital in Cleveland, she completed a fellowship in pediatric hematology/oncology at Children's National Medical Center, Washington, D.C. Dr. Jubran is a member of the retinoblastoma committee of the national Children's Oncology Group and one of the founding members of the North American Consortium for Histiocytic Disorders. Her investigations focus on retinoblastoma and Langerhans cell histiocytosis. A frequent lecturer and author, she is an active member of the international Histiocytosis Society. She serves on the Board of the Kevin Cordasco Foundation and the Histiocyte Association.

    Collapse ORNG Applications 
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatr Blood Cancer. 2024 Jan; 71(1):e30718. Chintagumpala M, Piao J, Gombos D, Chevez-Barrios P, Brock L, Dunkel IJ, Jubran R, Leahey AM, Kim J, O'Brien J, Shields CL, Rodriguez-Galindo C. PMID: 37817345; PMCID: PMC10842937.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). J Clin Oncol. 2022 11 20; 40(33):3839-3847. Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. PMID: 35820112; PMCID: PMC9671757.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    3. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study. Ophthalmology. 2022 08; 129(8):933-945. Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brennan RC, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-Mora J, Correa-Llano G, Carreras E, American Joint Committee on Cancer Ophthalmic Oncology Task Force. PMID: 35500608; PMCID: PMC9329221.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    4. High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study. Ophthalmology. 2022 08; 129(8):923-932. Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brennan RC, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-Mora J, Correa-Llano G, Carreras E, American Joint Committee on Cancer Ophthalmic Oncology Task Force. PMID: 35436535; PMCID: PMC9329269.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023 01; 107(1):127-132. Tomar AS, Finger PT, Gallie B, Kivelä T, Mallipatna A, Zhang C, Zhao J, Wilson M, Brennan R, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganeshan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef Y, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada GL, Schaiquevich P, Fandiño AC, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-Mora J, Correa Llano M, Carreras E, American Joint Committee on Cancer Ophthalmic Oncology Task Force, American Joint Committee on Cancer Ophthalmic Oncology Task. PMID: 34340974; PMCID: PMC9205754.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy. NPJ Precis Oncol. 2021 Jul 27; 5(1):73. Wong EY, Xu L, Shen L, Kim ME, Polski A, Prabakar RK, Shah R, Jubran R, Kim JW, Biegel JA, Gai X, Kuhn P, Hicks J, Berry JL. PMID: 34316014; PMCID: PMC8316348.
      View in: PubMed   Mentions: 7  
    7. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers (Basel). 2021 Mar 13; 13(6). Xu L, Kim ME, Polski A, Prabakar RK, Shen L, Peng CC, Reid MW, Chévez-Barrios P, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Biegel JA, Gai X, Hicks J, Berry JL. PMID: 33805776; PMCID: PMC8001323.
      View in: PubMed   Mentions: 19  
    8. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatr Blood Cancer. 2021 05; 68(5):e28964. Berry JL, Munier FL, Gallie BL, Polski A, Shah S, Shields CL, Gombos DS, Ruchalski K, Stathopoulos C, Shah R, Jubran R, Kim JW, Mruthyunjaya P, Marr BP, Wilson MW, Brennan RC, Chantada GL, Chintagumpala MM, Murphree AL. PMID: 33624399; PMCID: PMC8049511.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers. Sci Rep. 2021 01 08; 11(1):94. Cambier L, Stachelek K, Triska M, Jubran R, Huang M, Li W, Zhang J, Li J, Cobrinik D. PMID: 33420117; PMCID: PMC7794510.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    10. Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients. Transl Vis Sci Technol. 2020 09; 9(10):30. Polski A, Xu L, Prabakar RK, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Hicks J, Berry JL. PMID: 33062393; PMCID: PMC7533735.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    11. Intravitreal Melphalan for Retinoblastoma: The Impact of Toxicity on Recurrence and Ultimate Globe Salvage. Ocul Oncol Pathol. 2020 Dec; 6(6):388-394. Berry JL, Kim ME, Pefkianaki M, Reid M, Shah R, Jubran R, Kim JW. PMID: 33447588; PMCID: PMC7772881.
      View in: PubMed   Mentions: 3  
    12. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic Genet. 2020 12; 41(6):526-532. Xu L, Shen L, Polski A, Prabakar RK, Shah R, Jubran R, Kim JW, Biegel J, Kuhn P, Cobrinik D, Hicks J, Gai X, Berry JL. PMID: 32799607; PMCID: PMC7806277.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatr Blood Cancer. 2020 09; 67(9):e28502. Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M. PMID: 32589362; PMCID: PMC7857974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes Chromosomes Cancer. 2020 10; 59(10):584-590. Polski A, Xu L, Prabakar RK, Gai X, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Hicks J, Berry JL. PMID: 32390242; PMCID: PMC7441809.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    15. Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Mol Cancer Res. 2020 08; 18(8):1166-1175. Xu L, Polski A, Prabakar RK, Reid MW, Chevez-Barrios P, Jubran R, Kim JW, Kuhn P, Cobrinik D, Hicks J, Berry JL. PMID: 32434859; PMCID: PMC7415535.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    16. Aqueous Humor Is Superior to Blood as a Liquid Biopsy for Retinoblastoma. Ophthalmology. 2020 04; 127(4):552-554. Berry JL, Xu L, Polski A, Jubran R, Kuhn P, Kim JW, Hicks J. PMID: 31767439; PMCID: PMC7093221.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    17. A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines. Int Ophthalmol Clin. 2019; 59(2):65-75. Berry JL, Kogachi K, Murphree AL, Jubran R, Kim JW. PMID: 30908280; PMCID: PMC6676476.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. An Intraocular Pressure Predictive of High-risk Histopathologic Features in Group E Retinoblastoma Eyes. Int Ophthalmol Clin. 2019; 59(2):77-86. Kim ME, Shah S, Zolfaghari E, Jubran R, Reid MW, Kim JW, Berry JL. PMID: 30908281; PMCID: PMC6681901.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Posterior Vitreous Detachment and the Associated Risk of Retinal Toxicity with Intravitreal Melphalan Treatment for Retinoblastoma. Ocul Oncol Pathol. 2019 Jun; 5(4):238-244. Berry JL, Lee R, Patel L, Le BHA, O'Fee J, Jubran R, Kim JW. PMID: 31367584; PMCID: PMC6615322.
      View in: PubMed   Mentions: 5  
    20. Lurking below: massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma. Ophthalmic Genet. 2018 10; 39(5):653-657. Kogachi K, Kim JW, Green S, Jubran R, Berry JL. PMID: 30142285; PMCID: PMC6613565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Mol Cancer Res. 2018 11; 16(11):1701-1712. Berry JL, Xu L, Kooi I, Murphree AL, Prabakar RK, Reid M, Stachelek K, Le BHA, Welter L, Reiser BJ, Chévez-Barrios P, Jubran R, Lee TC, Kim JW, Kuhn P, Cobrinik D, Hicks J. PMID: 30061186; PMCID: PMC6214755.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    22. Integrated Treatment during the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic Chemoreduction. Ocul Oncol Pathol. 2018 Nov; 4(6):335-340. Berry JL, Shah S, Kim F, Jubran R, Kim JW. PMID: 30574483; PMCID: PMC6288714.
      View in: PubMed   Mentions: 4  
    23. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing. Ophthalmic Genet. 2018 06; 39(3):407-409. Berry JL, Lewis L, Zolfaghari E, Green S, Le BHA, Lee TC, Murphree AL, Kim JW, Jubran R. PMID: 29286867; PMCID: PMC7446179.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Loss of fundus view as an indication for secondary enucleation in retinoblastoma. Pediatr Blood Cancer. 2018 04; 65(4). Berry JL, Kogachi K, Jubran R, Kim JW. PMID: 29218818; PMCID: PMC7446180.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Three presentations of CNS disease in patients with intraocular retinoblastoma at a tertiary medical center in the United States. Ophthalmic Genet. 2018 Jan-Feb; 39(1):115-119. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry JL. PMID: 28949779.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatr Blood Cancer. 2017 Dec; 64(12). Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. PMID: 28646513.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    27. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 12; 124(12):1817-1825. Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. PMID: 28655537.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    28. Clinical Significance of Optic Nerve Enhancement on Magnetic Resonance Imaging in Enucleated Retinoblastoma Patients. Ophthalmol Retina. 2017 Sep - Oct; 1(5):369-374. Kim JW, Madi I, Lee R, Zolfaghari E, Jubran R, Lee TC, Murphree AL, Berry JL. PMID: 31047563; PMCID: PMC7448757.
      View in: PubMed   Mentions: 3     Fields:    
    29. Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma. Ophthalmol Retina. 2017 Sep - Oct; 1(5):361-368. Kim JW, Aziz HA, McGovern K, Zolfaghari E, Jubran RF, Murphree AL, Berry JL. PMID: 31047562; PMCID: PMC7448755.
      View in: PubMed   Mentions: 1     Fields:    
    30. Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion? Ocul Oncol Pathol. 2017 Nov; 3(4):283-291. Berry JL, Zolfaghari E, Chen A, Murphree AL, Jubran R, Kim JW. PMID: 29344482; PMCID: PMC5757559.
      View in: PubMed   Mentions: 3  
    31. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Jul; 64(7). Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT. PMID: 28019092; PMCID: PMC5651987.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    32. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 04; 64(4). Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. PMID: 28221729; PMCID: PMC7034314.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    33. Measuring pediatric hematology-oncology fellows' skills in humanism and professionalism: A novel assessment instrument. Pediatr Blood Cancer. 2017 05; 64(5). Kesselheim JC, Agrawal AK, Bhatia N, Cronin A, Jubran R, Kent P, Kersun L, Rao AN, Rose M, Savelli S, Sharma M, Shereck E, Twist CJ, Wang M. PMID: 27808467.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatr Blood Cancer. 2016 10; 63(10):1723-30. Zweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. PMID: 27295503.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 12; 37(4):400-403. Berry JL, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. PMID: 26934665.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. PMID: 27172535; PMCID: PMC4847672.
      View in: PubMed   Mentions: 6  
    37. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec; 2(2):76-9. Jacobsen BH, Berry JL, Jubran R, Kim JW. PMID: 27171650; PMCID: PMC4847708.
      View in: PubMed   Mentions: 2  
    38. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2162-6. Chellapandian D, Shaikh F, van den Bos C, Somers GR, Astigarraga I, Jubran R, Degar B, Carret AS, Mandel K, Belletrutti M, Dix D, Visser J, Abuhadra N, Chang T, Rollins B, Whitlock J, Weitzman S, Abla O. PMID: 26179251.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. Berry JL, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. PMID: 27172253; PMCID: PMC4847682.
      View in: PubMed   Mentions: 10  
    40. Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31. Tran HC, Marachelian A, Venkatramani R, Jubran RF, Mascarenhas L. PMID: 25551355.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    41. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution. J Pediatr Orthop. 2014 Dec; 34(8):825-30. Kamath S, Arkader A, Jubran RF. PMID: 25387157.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis. Am J Clin Oncol. 2014 Dec; 37(6):592-6. Kotecha R, Venkatramani R, Jubran RF, Arkader A, Olch AJ, Wong K. PMID: 23466581.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Br J Ophthalmol. 2014 Aug; 98(8):1061-5. Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. PMID: 24671926.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. Simultaneous colonic adenocarcinoma and medulloblastoma in a 12-year-old with biallelic deletions in PMS2. J Pediatr. 2013 Aug; 163(2):601-3. Lindsay H, Jubran RF, Wang L, Kipp BR, May WA. PMID: 23582141; PMCID: PMC3862975.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013 Feb; 60(2):175-84. Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, Egeler RM, Janka G, Micic D, Rodriguez-Galindo C, Van Gool S, Visser J, Weitzman S, Donadieu J, Euro Histio Network. PMID: 23109216; PMCID: PMC4557042.
      View in: PubMed   Mentions: 189     Fields:    Translation:Humans
    46. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013 Apr; 60(4):688-93. Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL. PMID: 22997170.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    47. Symptoms before and after posterior fossa surgery in pediatric patients. Pediatr Neurosurg. 2012; 48(1):21-5. Beckwitt Turkel S, Krieger MD, O'Neil S, Jubran R, Tavaré CJ. PMID: 22832661.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Graduate medical education changes: yes we can or enough already? Pediatr Blood Cancer. 2012 Dec 15; 59(7):1168-72. Leavey PJ, Jubran RF. PMID: 22488867.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012 Dec 15; 59(7):1324-6. Venkatramani R, Rosenberg S, Indramohan G, Jeng M, Jubran R. PMID: 22434707.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    50. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer. 2012 Jun; 58(6):905-9. Gozali AE, Britt B, Shane L, Gonzalez I, Gilles F, McComb JG, Krieger MD, Lavey RS, Shlien A, Villablanca JG, Erdreich-Epstein A, Dhall G, Jubran R, Tabori U, Malkin D, Finlay JL. PMID: 21990040.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    51. Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation. Int J Cancer. 2011 May 15; 128(10):2393-404. Bunin GR, Felice MA, Davidson W, Friedman DL, Shields CL, Maidment A, O'Shea M, Nichols KE, Leahey A, Dunkel IJ, Jubran R, Rodriguez-Galindo C, Schmidt ML, Weinstein JL, Goldman S, Abramson DH, Wilson MW, Gallie BL, Chan HS, Shapiro M, Cnaan A, Ganguly A, Meadows AT. PMID: 20648557; PMCID: PMC3124307.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. The role of chemotherapy in pediatric clival chordomas. J Neurooncol. 2011 Jul; 103(3):657-62. Dhall G, Traverso M, Finlay JL, Shane L, Gonzalez-Gomez I, Jubran R. PMID: 21052774.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    53. Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. J Neurooncol. 2011 Jul; 103(3):673-80. Parekh C, Jubran R, Erdreich-Epstein A, Panigrahy A, Bluml S, Finlay J, Dhall G. PMID: 21038110.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    54. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer. 2010 Jul 15; 55(1):42-6. Khatua S, Dhall G, O'Neil S, Jubran R, Villablanca JG, Marachelian A, Nastia A, Lavey R, Olch AJ, Gonzalez I, Gilles F, Nelson M, Panigrahy A, McComb G, Krieger M, Fan J, Sposto R, Finlay JL. PMID: 20222020.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    55. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010 Jul 15; 55(1):149-52. Dunkel IJ, Chan HS, Jubran R, Chantada GL, Goldman S, Chintagumpala M, Khakoo Y, Abramson DH. PMID: 20486181.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    56. Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer. 2010 Mar; 54(3):384-7. Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S, Khakoo Y, O'Brien JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM, Abramson DH. PMID: 19908299.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    57. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Cancer. 2009 Jul 01; 115(13):2956-63. Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL. PMID: 19402050.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    58. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Pediatr Blood Cancer. 2008 Oct; 51(4):479-84. Armenian SH, Panigrahy A, Murphree AL, Jubran RF. PMID: 18478574.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    59. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatr Blood Cancer. 2008 Mar; 50(3):715-7. Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL. PMID: 17009232.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    60. A case of composite neuroblastoma composed of histologically and biologically distinct clones. Pediatr Dev Pathol. 2007 May-Jun; 10(3):229-32. Sano H, Gonzalez-Gomez I, Wu SQ, Armenian SH, Jubran RF, Shimada H. PMID: 17535087.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    61. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005 Jul; 45(1):37-42. Jubran RF, Marachelian A, Dorey F, Malogolowkin M. PMID: 15768381.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    62. Disordered respiratory control in children with partial cerebellar resections. Pediatr Pulmonol. 2005 Jul; 40(1):88-91. Chen ML, Witmans MB, Tablizo MA, Jubran RF, Turkel SB, Tavaré CJ, Keens TG. PMID: 15880401.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. Central nervous system germ cell tumors: controversies in diagnosis and treatment. Oncology (Williston Park). 2005 May; 19(6):705-11; discussion 711-2, 715-7, 721. Jubran RF, Finlay J. PMID: 15971448.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol. 2004 Jan; 26(1):31-4. Jubran RF, Erdreich-Epstein A, Butturini A, Murphree AL, Villablanca JG. PMID: 14707710.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    65. GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis. 2000 Mar; 30(3):569-71. Handa A, Jubran RF, Dickstein B, Boylan A, Luban NL, Young NS, Brown KE. PMID: 10722444.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    66. Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light. Ther Drug Monit. 1998 Apr; 20(2):236-9. Jubran RF, Dinndorf PA. PMID: 9558141.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Rima's Networks
    Concepts (234)
    Derived automatically from this person's publications.
    Co-Authors (25)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department